Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
AUTOR(ES)
Leder, Benjamin Z.
FONTE
The Endocrine Society
RESUMO
Context: In postmenopausal women, bone mineral density (BMD) declines after teriparatide therapy is stopped. The pattern of BMD loss after teriparatide therapy is stopped in men is less clear.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2730878Documentos Relacionados
- Effects of Teriparatide Retreatment in Osteoporotic Men and Women
- Markers of autoimmune liver diseases in postmenopausal women with osteoporosis
- Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS)
- Treatment of postmenopausal osteoporosis: Author's reply
- Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosis